CD137 Antibodies Clinical Trials & Market Opportunity - Revolutionary CD137 Antibodies Poised to Transform Cancer Immunotherapy Landscape by 2027
12 sept. 2024 04h01 HE
|
Research and Markets
Dublin, Sept. 12, 2024 (GLOBE NEWSWIRE) -- The "CD137 Antibodies Clinical Trials & Market Opportunity Insight 2027" report has been added to ResearchAndMarkets.com's offering. CD137, also...
CD47 Inhibitor Drug Clinical Trials Market Outlook to 2028 - Emerging CD47 Inhibitor Clinical Trials Showcase Potential Cancer Treatment Breakthroughs
06 sept. 2024 06h48 HE
|
Research and Markets
Dublin, Sept. 06, 2024 (GLOBE NEWSWIRE) -- The "Global CD47 Inhibitor Drug Clinical Trials Insight & Market Opportunity Outlook 2028" report has been added to ResearchAndMarkets.com's offering....
Turkey Cancer Drugs Clinical Trials Market Research 2024 Featuring OMEGA CRO, mediSMART, CRM-CRO, CROTURK, and Klinar CRO
05 sept. 2024 04h21 HE
|
Research and Markets
Dublin, Sept. 05, 2024 (GLOBE NEWSWIRE) -- The "Turkey Cancer Drugs Clinical Trials Insight 2024" report has been added to ResearchAndMarkets.com's offering. Turkey presents an expanding...
Preclinical Imaging (In-VIVO) Strategic Research Report 2023-2030: Adoption of AI and Machine Learning in Image Analysis Drives Market Dynamics
30 août 2024 05h38 HE
|
Research and Markets
Dublin, Aug. 30, 2024 (GLOBE NEWSWIRE) -- The "Preclinical Imaging (In-VIVO) - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for...
Pharma and Biotech Preclinical Stage Partnering Terms and Agreements Analysis Report and Directory 2024: Essential Benchmark Data for Dealmakers - Royalty Rates, Deal Financials, Contract Documents
27 août 2024 04h04 HE
|
Research and Markets
Dublin, Aug. 27, 2024 (GLOBE NEWSWIRE) -- The "Global Preclinical Stage Partnering Terms and Agreements in Pharma and Biotech 2019-2024" report has been added to ResearchAndMarkets.com's offering. ...
MCL1 Inhibitor Drug Clinical Trials & Commercialization Opportunity Insights Analysis 2024: Focus on 10 ML1 Inhibitor Drug In Clinical Trials, Insight By Company, Indication and Phase
26 août 2024 11h02 HE
|
Research and Markets
Dublin, Aug. 26, 2024 (GLOBE NEWSWIRE) -- The "MCL1 Inhibitor Drug Clinical Trials & Commercialization Opportunity Insights 2024" report has been added to ResearchAndMarkets.com's offering. ...
Project Mosaic Launches to Bring “Biopsies” to ALS Drug Development
21 août 2024 13h10 HE
|
Project Mosaic
Project Mosaic is proud to announce the launch of a groundbreaking initiative aimed at revolutionizing ALS drug development.
Preclinical Imaging Industry Research 2023-2029
16 août 2024 05h48 HE
|
Research and Markets
Dublin, Aug. 16, 2024 (GLOBE NEWSWIRE) -- The "Global Preclinical Imaging Market Size, Share & Trends by Product Type (Optical Imaging, PET, SPECT, Optical Imaging Reagents, Contrast Agents,...
TROP2 Antibody Market & Clinical Trials Report to 2029: Global & Regional Market Insight and Coverage of 45 Drugs In Clinical Trials
15 août 2024 10h14 HE
|
Research and Markets
Dublin, Aug. 15, 2024 (GLOBE NEWSWIRE) -- The "TROP2 Antibody Market & Clinical Trials Insight 2029" report has been added to ResearchAndMarkets.com's offering. TROP2 (trophoblast cell...
CRISPR Cas9 Market and Clinical Trials Report to 2029: CRISPR-Cas9 Therapy Clinical Trials By Company, County, Indication & Phase
12 août 2024 04h52 HE
|
Research and Markets
Dublin, Aug. 12, 2024 (GLOBE NEWSWIRE) -- The "CRISPR Cas9 Market Opportunity & Clinical Trials Outlook 2029" report has been added to ResearchAndMarkets.com's offering. The global landscape...